Literature DB >> 1747859

Histoplasma variation and adaptive strategies for parasitism: new perspectives on histoplasmosis.

L G Eissenberg1, W E Goldman.   

Abstract

This review summarizes the biology of Histoplasma capsulatum in relation to a wide variety of corresponding pathologies in histoplasmosis. Features of these disease syndromes can be explained in part by natural variations within the fungal population and adaptations made by individual organisms to specific environments. H. capsulatum grows as mycelia and conidia in the soil; once inhaled, the organism undergoes a dramatic morphological and physiological conversion to a yeast form. The yeasts proliferate within the phagolysosomes of macrophages, using a variety of specific strategies for intracellular survival. Even avirulent strains or variants are able to avoid being killed by macrophages and instead establish inapparent or persistent infections. The ingested avirulent organisms assume enlarged shapes similar in appearance to those seen in histological sections of tissues from patients with histoplasmosis. Respiratory tract epithelial cells also appear to play a role in persistence: within them yeasts undergo phenotypic switching akin to the phase variation observed in other pathogens. This particular change involves the loss or modification of cell wall alpha-(1,3)-glucan, which is also correlated with the spontaneous appearance of avirulent variants. The repertoire of adaptive responses and natural variations within this species probably evolved from the need to adjust to a wide range of dynamic environments. In combination with the immune status of the host, these characteristics of H. capsulatum appear to influence the epidemiology, extent, and persistence of histoplasmosis.

Entities:  

Mesh:

Year:  1991        PMID: 1747859      PMCID: PMC358209          DOI: 10.1128/CMR.4.4.411

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  113 in total

1.  Oxygen-dependent microbial killing by phagocytes (first of two parts).

Authors:  B M Babior
Journal:  N Engl J Med       Date:  1978-03-23       Impact factor: 91.245

2.  Cystine reductase in the dimorphic fungus Histoplasma capsulatum.

Authors:  B Maresca; E Jacobson; G Medoff; G Kobayashi
Journal:  J Bacteriol       Date:  1978-09       Impact factor: 3.490

3.  Identification of coprogen B and its breakdown products from Histoplasma capsulatum.

Authors:  W R Burt
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

4.  Interactions between Histoplasma capsulatum and macrophages from normal and treated mice: comparison of the mycelial and yeast phases in alveolar and peritoneal macrophages.

Authors:  C L Kimberlin; A R Hariri; H O Hempel; N L Goodman
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

5.  Association of HLA-DRw2 antigen with presumed ocular histoplasmosis.

Authors:  T A Meredith; R E Smith; R J Duquesnoy
Journal:  Am J Ophthalmol       Date:  1980-01       Impact factor: 5.258

6.  Cell wall analysis of an adenine-requiring mutant of the yeast-like form of Paracoccidioides brasiliensis strain IVIC Pb9.

Authors:  G San-Blas; F San-Blas; E Ormaechea; L E Serrano
Journal:  Sabouraudia       Date:  1977-11

7.  Host-parasite relationships in the yeastlike form of Paracoccidioides brasiliensis strain IVIC Pb9.

Authors:  G San-Blas; F San-Blas; L E Serrano
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

8.  Transferrin-dependent growth inhibition of yeast-phase Histoplasma capsulatum by human serum and lymph.

Authors:  M C Sutcliffe; A M Savage; R H Alford
Journal:  J Infect Dis       Date:  1980-08       Impact factor: 5.226

9.  Induction of the synthesis of cell wall alpha-1,3-glucan in the yeastlike form of Paracoccidioides brasiliensis strain IVIC Pb9 by fetal calf serum.

Authors:  G San-Blas; D Vernet
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

10.  Failure to trigger the oxidative metabolic burst by normal macrophages: possible mechanism for survival of intracellular pathogens.

Authors:  C B Wilson; V Tsai; J S Remington
Journal:  J Exp Med       Date:  1980-02-01       Impact factor: 14.307

View more
  45 in total

1.  Mouse models for the study of fungal pneumonia: a collection of detailed experimental protocols for the study of Coccidioides, Cryptococcus, Fusarium, Histoplasma and combined infection due to Aspergillus-Rhizopus.

Authors:  Maged Muhammed; Marta Feldmesser; Lisa F Shubitz; Michail S Lionakis; Anita Sil; Yan Wang; Justin Glavis-Bloom; Russell E Lewis; John N Galgiani; Arturo Casadevall; Dimitrios P Kontoyiannis; Eleftherios Mylonakis
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

2.  Identification of a copper-inducible promoter for use in ectopic expression in the fungal pathogen Histoplasma capsulatum.

Authors:  Dana Gebhart; Adam K Bahrami; Anita Sil
Journal:  Eukaryot Cell       Date:  2006-06

3.  Primary Central Nervous System Infection by Histoplasma in an Immunocompetent Adult.

Authors:  Sérgio M de Almeida; Elaine C M Imano; Vania A Vicente; Renata R Gomes; Ana P Trentin; Kassiely Zamarchi; Gabriela X Schneider; Rosangela L Pinheiro; Nickolas M da Silva; G S de Hoog
Journal:  Mycopathologia       Date:  2020-01-27       Impact factor: 2.574

4.  Spectroscopic and kinetic studies of Nor1, a cytochrome P450 nitric oxide reductase from the fungal pathogen Histoplasma capsulatum.

Authors:  Lily Y Chao; Jasper Rine; Michael A Marletta
Journal:  Arch Biochem Biophys       Date:  2008-09-10       Impact factor: 4.013

Review 5.  Coevolution of morphology and virulence in Candida species.

Authors:  Delma S Thompson; Patricia L Carlisle; David Kadosh
Journal:  Eukaryot Cell       Date:  2011-07-15

6.  Altered expression of surface alpha-1,3-glucan in genetically related strains of Blastomyces dermatitidis that differ in virulence.

Authors:  L H Hogan; B S Klein
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  Soluble components of Histoplasma capsulatum var. capsulatum have hemagglutinin activity and induce syngeneic hemophagocytosis in vitro.

Authors:  R H F Vivan; P C Leonello; L A Nagashima; M S Kaminami; F S M Tristão; A Sano; M A Ono; C V Béjar; E N Itano
Journal:  Mycopathologia       Date:  2009-11-08       Impact factor: 2.574

8.  PCR assay for identification of histoplasma capsulatum based on the nucleotide sequence of the M antigen.

Authors:  Herbert Leonel de Matos Guedes; Allan Jefferson Guimarães; Mauro de Medeiros Muniz; Claudia Vera Pizzini; Andrew John Hamilton; José Mauro Peralta; George S Deepe; Rosely M Zancopé-Oliveira
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

9.  Macrophage cell death and transcriptional response are actively triggered by the fungal virulence factor Cbp1 during H. capsulatum infection.

Authors:  Dervla T Isaac; Charlotte A Berkes; Bevin C English; Davina Hocking Murray; Young Nam Lee; Alison Coady; Anita Sil
Journal:  Mol Microbiol       Date:  2015-09-29       Impact factor: 3.501

10.  Molecular characterization of Histoplasma capsulatum isolated from an outbreak in treasure hunters Histoplasma capsulatum in treasure hunters.

Authors:  Bertha Muñoz; María A Martínez; Gabriel Palma; Amado Ramírez; María G Frías; María R Reyes; María L Taylor; Anjarath L Higuera; Alexander Corcho; María E Manjarrez
Journal:  BMC Infect Dis       Date:  2010-09-08       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.